Filtered By:
Source: Europace
Condition: Heart Disease
Nutrition: Vitamin K
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation
ConclusionIn a contemporary setting among VKA-experienced NVAF patients; VKA is still prevalent although about 30% by December 2015 had shifted to a NOAC.
Source: Europace - June 28, 2017 Category: Cardiology Source Type: research
